Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data

Moderna shares are taking a hit after the leak of highly anticipated details about the company's vaccine for the skin cancer melanoma.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。